<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[0, 1] Quality<br>[2, 5] individual INR control<br>[6, 10] the risk of stroke<br>[11, 12] bleeding<br>[31, 32] Time<br>[33, 38] therapeutic range (TTR)<br>[102, 109] anticoagulation quality measures were compared, overall<br>[110, 117] in a time-dependent manner.<br>[171, 173] mean TTR<br>[175, 177] stroke cases<br>[185, 187] bleeding cases<br>[197, 208] Time below range for stroke and time above range for bleeding<br>[297, 301] stroke and bleeding.<br></td>
<td width=33%>
[0, 1] Quality<br>[2, 5] individual INR control<br>[6, 10] the risk of stroke<br>[11, 12] bleeding<br>[31, 38] Time in therapeutic range (TTR)<br>[102, 109] anticoagulation quality measures were compared, overall<br>[110, 117] in a time-dependent manner.<br>[170, 177] study mean TTR of both stroke cases<br>[185, 187] bleeding cases<br>[197, 208] Time below range for stroke and time above range for bleeding<br>[297, 301] stroke and bleeding.<br></td>
<td width=33%>
[0, 13] Quality of individual INR control and the risk of stroke and bleeding events<br>[31, 45] Time in therapeutic range (TTR) for international normalized ratio (INR)<br>[47, 50] accepted quality measure<br>[61, 65] predicting stroke and bleeding<br>[102, 117] anticoagulation quality measures were compared, overall and in a time-dependent manner.<br>[160, 163] bleeding analysis.<br>[170, 177] study mean TTR of both stroke cases<br>[185, 187] bleeding cases<br>[197, 208] Time below range for stroke and time above range for bleeding<br>[235, 240] bleeding cases spent more time<br>[254, 257] TTR was lower<br>[262, 265] stroke or bleeding<br>[296, 301] prevent stroke and bleeding.<br></td>
</tr>
